Home › Eierstokkanker › Nebraska › Omaha
Eierstokkanker klinische studies in Omaha, NE
14 studies voor Eierstokkanker zoeken deelnemers op locaties in en rond Omaha (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RekruterenFase 1/2
- Nebraska Cancer Specialists, Omaha
- XCancer, Omaha
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RekruterenFase 1
- University Of Nebraska Medical Center /ID# 281020, Omaha
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RekruterenFase 1/2
- University of Nebraska Medical Center, Omaha
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RekruterenFase 3
- Nebraska Methodist Hospital ( Site 0004), Omaha
- University Of Nebraska Medical Center ( Site 0035), Omaha
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruterenFase 1/2
- Nebraska Cancer Specialists, Omaha
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruterenFase 2
- Nebraska Methodist Hospital, Omaha
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RekruterenFase 3
- Nebraska Methodist Hospital ( Site 0053), Omaha
Study of NTB-928 in R/R OC
RekruterenFase 1
- University of Nebraska Medical Center, Omaha
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekruteren
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- en nog 4
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruterenFase 3
- Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha
- Nebraska Methodist Hospital, Omaha
- Nebraska Medicine-Village Pointe, Omaha
- en nog 8
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruterenFase 2
- Nebraska Cancer Specialists - Midwest Cancer Center - Legacy, Omaha
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekruterenFase 1/2
- Nebraska Cancer Specialists, Omaha
Integrated Cancer Repository for Cancer Research
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Methodist Estabrook Cancer Center, Omaha
- Nebraska Methodist Health System, Omaha
- University of Nebraska Medical Center, Omaha
- en nog 1
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Omaha
Eierstokkanker studies in andere steden
- Houston, TX89 studies
- New York City, NY69 studies
- Boston, MA61 studies
- Los Angeles, CA50 studies
- Nashville, TN49 studies
- Arlington, VA46 studies
- Philadelphia, PA44 studies
- Columbus, OH39 studies
- St. Louis, MO38 studies
- Chicago, IL36 studies
- San Antonio, TX31 studies
- Cleveland, OH30 studies
Andere studies in Omaha
- Prostaatkanker27 studies
- Niet-kleincellige longkanker24 studies
- Borstkanker22 studies
- Kanker (alle vormen)18 studies
- Colorectale kanker18 studies
- Multipel myeloom16 studies
- Non-Hodgkinlymfoom14 studies
- Aldermeesklierkanker14 studies
- Metastatische kanker13 studies
- Plaveiselcelcarcinoom van hoofd en hals13 studies
- Hartfalen13 studies
- Melanoom12 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.